Gabapentin for the treatment of tremor

Ann Pharmacother. 2003 Feb;37(2):282-6. doi: 10.1177/106002800303700222.

Abstract

Objective: To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor.

Data sources: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans.

Data synthesis: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings.

Conclusions: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.

Publication types

  • Review

MeSH terms

  • Acetates / therapeutic use*
  • Adult
  • Aged
  • Amines*
  • Clinical Trials as Topic
  • Cyclohexanecarboxylic Acids*
  • Gabapentin
  • Humans
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Treatment Outcome
  • Tremor / classification
  • Tremor / drug therapy*
  • Tremor / etiology
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Amines
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin